Vestcor Inc Has $9.72 Million Stock Holdings in HCA Healthcare, Inc. $HCA

Vestcor Inc grew its position in HCA Healthcare, Inc. (NYSE:HCA) by 65.3% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 22,795 shares of the company’s stock after buying an additional 9,006 shares during the period. Vestcor Inc’s holdings in HCA Healthcare were worth $9,715,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Clearstead Trust LLC increased its holdings in shares of HCA Healthcare by 311.8% in the second quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock worth $27,000 after acquiring an additional 53 shares in the last quarter. Harbor Capital Advisors Inc. grew its position in shares of HCA Healthcare by 82.9% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock valued at $32,000 after purchasing an additional 34 shares during the period. Twin Peaks Wealth Advisors LLC acquired a new stake in HCA Healthcare during the 2nd quarter worth approximately $40,000. Compound Global Advisors LLC acquired a new position in shares of HCA Healthcare in the third quarter valued at approximately $44,000. Finally, True Wealth Design LLC raised its holdings in shares of HCA Healthcare by 179.5% during the third quarter. True Wealth Design LLC now owns 109 shares of the company’s stock worth $47,000 after acquiring an additional 70 shares during the period. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Stock Up 2.5%

NYSE:HCA opened at $545.88 on Tuesday. The firm has a market capitalization of $122.07 billion, a price-to-earnings ratio of 19.23, a price-to-earnings-growth ratio of 1.64 and a beta of 1.34. HCA Healthcare, Inc. has a twelve month low of $310.18 and a twelve month high of $552.90. The stock’s 50 day moving average price is $501.78 and its two-hundred day moving average price is $466.79.

HCA Healthcare (NYSE:HCA) last released its earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, beating the consensus estimate of $7.37 by $0.64. The business had revenue of $19.51 billion during the quarter, compared to analysts’ expectations of $19.67 billion. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The firm’s revenue was up 6.7% on a year-over-year basis. During the same period last year, the business earned $6.22 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be paid a $0.78 dividend. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.72. The ex-dividend date is Tuesday, March 17th. This represents a $3.12 annualized dividend and a yield of 0.6%. HCA Healthcare’s dividend payout ratio (DPR) is 10.15%.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on HCA shares. Barclays increased their target price on HCA Healthcare from $494.00 to $551.00 and gave the stock an “overweight” rating in a report on Wednesday, January 28th. Jefferies Financial Group increased their price objective on HCA Healthcare from $535.00 to $590.00 and gave the stock a “buy” rating in a report on Wednesday, January 28th. The Goldman Sachs Group boosted their target price on HCA Healthcare from $520.00 to $558.00 and gave the company a “buy” rating in a research note on Wednesday, January 28th. Sanford C. Bernstein set a $541.00 price objective on shares of HCA Healthcare in a report on Monday, February 9th. Finally, Leerink Partners increased their target price on shares of HCA Healthcare from $507.00 to $573.00 and gave the stock an “outperform” rating in a report on Wednesday, January 28th. Sixteen analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $534.50.

Insiders Place Their Bets

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 1,694 shares of the company’s stock in a transaction that occurred on Wednesday, February 18th. The stock was sold at an average price of $533.37, for a total value of $903,528.78. Following the sale, the executive vice president owned 8,853 shares in the company, valued at $4,721,924.61. This represents a 16.06% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Michael S. Cuffe sold 1,500 shares of HCA Healthcare stock in a transaction that occurred on Tuesday, February 3rd. The stock was sold at an average price of $498.09, for a total value of $747,135.00. Following the transaction, the executive vice president owned 30,003 shares of the company’s stock, valued at $14,944,194.27. This represents a 4.76% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 15,214 shares of company stock worth $7,797,595 in the last three months. 1.30% of the stock is owned by corporate insiders.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.